For more than forty years Meier has been transforming critical, close-tolerance metal components for the medical device, aerospace and defense industry
Richard (Rick) Meier started Meier Tool & Engineering in the basement of his home in 1979 as a tool design and die making company. For more than forty years Meier has been transforming critical, close-tolerance metal components for the medical device industry.
Over time, Meier has gained a wealth of experience servicing the medical device industry. Meier’s strengths in implantable devices, disposable instruments, biopsy forceps, drug delivery, electrosurgery, and hearing devices, offers an unprecedented network of knowledge and skills needed to meet the stringent demands in the medical industry. Meier serves many health care market segments including neurostimulation, cardiovascular, pacing, endoscopy, laparoscopy, electrosurgery, diabetes, hearing health, and orthopaedics, to name a few.
Cretex acquired Meier in 2008, providing Meier with the resources to expand capabilities and strengthening their ability to integrate and simplify the supply chain for their customers vertically. Cretex, a privately-owned group of companies for more than 100 years, with a long-term perspective and a strong financial portfolio, allows Meier to invest in the leading-edge technologies and resources required to meet today’s launch-critical time-lines with confidence. In the top 10% of medical device contract manufacturers, you can trust in a stable partnership moving your projects forward timely, cost-effectively and with a keen sense of understanding in mitigating your risks in the current global competitive environment.
Meier is passionate about understanding our customers’ objectives and supporting their success. Our employees deliver quality products that improve the safety and well-being of others through commitment, innovation, and dedication.
When value-add makes the difference
Meier invests in cost-effective technologies which simplify our customer’s supply chain and management of lifecycle costs of a product proactively.